STD Services Home Page
. 


Related Pages

Notifiable STDs

Contact tracing statistics for Clinic 275, 2005 

Notification information for clinicians

Sexually Transmitted Diseases Services
Surveillance System

Contents


Introduction

The surveillance unit of Sexually Transmitted Diseases (STD) Services collects information on the following notifiable diseases:

The primary purpose of surveillance is to direct statewide prevention and control activities. Important priorities are to determine the magnitude of the problem and current dynamics of disease transmission.

The information gained is used to:

  • enable epidemiologic analysis to inform policy decisions

  • determine the level of ongoing transmission

  • assess the burden of disease in the community

  • monitor the level of testing in the community.

To facilitate

  • investigation of cases where the mechanism of exposure is unclear

  • definition of the epidemiology of new infections

  • contact tracing/partner notification

  • identification of clusters associated with modes of transmission which may require specific public health interventions.

Legal Basis

Chlamydia, gonorrhoea, syphilis, and donovanosis are listed as notifiable diseases under the provisions of the Public and Environmental Health (P&EH) Act 1987. Sections 30 and 41 of the act allow for further investigation of cases when necessary. 

The controlled notifiable diseases, HIV, AIDS, hepatitis C and hepatitis B, are subject to the provisions of sections 31-34 of the act, these allow the Health Commission to require individuals to undergo examination or even confine cases if there is a threat to public health. The use of these powers under the act are subject to magisterial oversight and there is a right of appeal to the Supreme Court. Persons with a controlled notifiable disease are also obliged to take reasonable measures to prevent transmission to others.

The Public & Environmental Health Act (1987) as amended, provides a general legal framework for the collection of Notifiable Disease data and facilitates notification of the above infections by:

  • Placing a duty upon doctors and laboratories to forward relevant data on cases of these diseases, as designated in Section 30 of the Act, to STD Services as a designated authority for the South Australian Health Commission (SAHC).

  • Absolving the reporting doctor and laboratory from any legal liability concerning consent to release that information. Thus consent does not arise as an issue with regard to notifications made in good faith. 
    It is wise to inform the patient that their case will be notified and that they may be contacted during further investigation.

  • Preventing release by the SAHC (or designated authorities) of identifying data. Notification data containing personal details can only be secured by court order.

The format of reports, quantity and nature of data required are determined by the appropriate SAHC collection authority. Further information about disease notification in South Australia can be found on the South Australian Department of Health website. 

Reporting Mechanism

The system has two components:

  1. Laboratory: copies of all positive test results are sent to STD Services. Laboratory notification ensures that medical notifications are monitored.

  2. Medical: medical officers notify all newly diagnosed cases of infection to STD Services on the appropriate form. The surveillance unit sends notification forms and reply paid envelopes to the medical officer for each new case of gonorrhoea, genital chlamydia, syphilis, HIV infection, hepatitis B infection, hepatitis C infection and donovanosis.

Data Collection

Basic demographic data, date of test and where appropriate, testing history, some clinical information and transmission risk factor data are routinely collected. Data are checked for accuracy and entered on to the STD surveillance database. 

In the case of the blood borne infections, if the notifying doctor has indicated  that the patient has had previous negative test, this information is validated by contacting the laboratory. If risk factor information is unknown or not stated, the patient is contacted to ascertain their risk factor.

Analysis

Data are analysed using Stata software (version 8).

Analysis is performed quarterly and yearly according to sex, age, marital status, exposure category and racial origin. For the blood borne infections, data are also analysed by case category.

Interpretation

Surveillance data are descriptive by nature and therefore caution must be applied when interpreting the information.

Dissemination

Data are published on the internet and in annual epidemiologic reports. Summaries are distributed electronically in quarterly reports. Information is forwarded to state and national surveillance bodies on a regular basis. Analyses are prepared and distributed for specific purposes, as requested.

South Australian Surveillance Definitions

Genital Chlamydial Infection

  • Isolation of Chlamydia trachomatis from a clinical (genital) specimen.
    or

  • Demonstration of Chlamydia trachomatis in a clinical (genital) specimen by nucleic acid detection methods.
    or

  • Demonstration of Chlamydia trachomatis in a clinical (genital) specimen by antigen detection methods.
    or

  • Demonstration of Chlamydia trachomatis in a urine specimen by PCR.

Gonococcal Infection

  • Isolation of Neisseria gonorrhoeae from a clinical specimen.
    or

  • Demonstration of Neisseria gonorrhoeae in a urine specimen by PCR.

Syphilis

Primary syphilis

  • Demonstration of Treponema pallidum by darkfield microscopy in lesions from the anogenital area. There is no merit in performing this test on oral lesions because other treponemes, microscopically indistinguishable from T. Pallidum, occur in the mouth.
  • A presumptive diagnosis can be made if a typical ulcer is associated with a consistent history of syphilis in sex partners and/or serologic pattern before or after treatment in the patient.

Secondary syphilis

  • Typical lesions of secondary syphilis (rash, condylomata, alopecia) and a consistent serologic pattern before and/or after treatment. A rising RPR titre before treatment (fourfold within 6 months) and a corresponding fall after treatment. In secondary syphilis the RPR titre will usually be 1:8 or greater.

Early latent syphilis

An asymptomatic patient with positive RPR and TPHA and one of the following:

  • negative serology within the previous 2 years

  • fourfold increase in RPR titre on subsequent testing

  • fourfold decline in RPR within 12 months after treatment.

Late syphilis

Late symptomatic syphilis is suggested when a positive treponemal test (RPR may be negative) occurs in association with typical neurological or cardiovascular signs.

Late latent syphilis

Characterised by a positive treponemal test (TPHA of FTA-ABS) and a negative or stable low titre RPR test. This same pattern may be due to adequately treated syphilis or a false positive treponemal test.

Hepatitis C Infection

  • Demonstration of anti-HCV antibodies.
    or

  • Demonstration of HCV RNA by PCR.

All positive tests for HCV infection are notified to STD Services where cases are classified as:

Incident case (infection of less than 12 months duration)

  • Negative serology in the preceding 12 months
    or

  • clinical illness consistent with acute hepatitis C within the last twelve months, where other causes of acute hepatitis can be excluded.

Infection likely to be greater than 12 months

  • Documented positive test result more than 12 months ago
    or
  • history of diagnosed clinical illness more than 12 months ago
    or
  • risk behaviour confined to more than 12 months ago.

Infection of uncertain duration

No evidence of a previous test, and clinical illness not diagnosed.

Note:  Indeterminate Test Results

For surveillance purposes an indeterminate test result is regarded as negative. However, some cases may represent seroconversion and retesting is often indicated.

Hepatitis B Infection

  • Demonstration of hepatitis B surface antigen in serum.

All positive tests for HBV infection are notified to STD Services where cases are classified as:

Acute infection

  • Elevated ALT consistent with acute infection

and

  • diagnosed acute clinical illness - may include jaundice or bilirubin elevated, or at least two of the following: fever, anorexia, myalgia, abdominal pain, lethargy
    or

  • HBV core IgM antibody positive.

Infection less than 12 months

  • Negative serology in the preceding 12 months.

Infection likely to be greater than 12 months

  •  Positive serology more than 12 months ago
     or

  • history of diagnosed clinical illness more than 12 months ago.

Uncertain Duration

  • No evidence of a previous test, and clinical illness not diagnosed.

 

HIV Infection

  • Demonstration of HIV antibodies by EIA

and

  • Western Blot positive or detection of HIV.

All positive tests for HIV infection are notified to STD Services where cases are classified as:

Incident Case

  • Negative serology in the preceding 12 months
    or

  • diagnosed seroconversion illness in the preceding 12 months.

Infection likely to be greater than 12 months

  • Risk behaviour confined to more than 12 months ago
    or

  • diagnosed seroconversion illness more than 12 months ago.

Uncertain duration

  • Tested for the first time and no seroconversion illness
    or

  • AIDS defining illness present.
Related Pages

Top of Page

 

Home | Search | Contents | About STD Services  | Clinic 275  | Clinicians | DiseasesNotifications | Other STD ClinicsPamphlets | Statistics | Web Links | Your Sexual Health   

Royal Adelaide Hospital Home Page
Royal Adelaide Hospital

Copyright © Department of Health 2005

Disclaimer

About this web site 
Last updated: 09 August 2007
URL:http://pubstd.health.sa.gov.au/notification/surveillance_system.htm

           
Health on the Net Code of ConductHealth on the Net Code of Conduct for health-related sites

        Healthy SA

South Australia Central

Sexually Transmitted Diseases Services
Internal Medicine Service
Royal Adelaide Hospital
First Floor, 275 North Terrace
Adelaide  SA  5000
Australia

Telephone: +61 (8) 8222 5075
Facsimile:   +61 (8) 8232 3504
Email: STD.Services AT health.sa.gov.au
Web site comments and enquiries: 
Joy.Copland AT health.sa.gov

Please relace the word AT with the @ symbol to email comments.